Form 4: Fractyl Health Director Royan Ajay Acquires Shares in Open Market

Director Royan Ajay reports purchasing 17,901 shares of Fractyl Health at a weighted average price of $1.2837 on March 14, 2025.

Summary

• On March 14, 2025, Royan Ajay, a director of Fractyl Health, Inc., acquired 17,901 shares of common stock at a weighted average price of $1.2837.
• The shares were purchased in multiple transactions with prices ranging from $1.22 to $1.32.
• Following the transaction, Royan Ajay also indirectly owns 5,160,301 shares through Mithril LP and 1,251,900 shares through Mithril II LP.
• He disclaims beneficial ownership of these indirectly held shares except to the extent of his pecuniary interest.

Sentiment

Score: 6

Explanation: The sentiment is neutral. It's a standard disclosure of a director purchasing shares, which could be seen as a positive signal, but without more context, it's difficult to gauge the overall impact.

Positives

• The director's purchase of shares could be interpreted as a sign of confidence in the company's future prospects.

Industry Context

This Form 4 filing is a routine disclosure required by the SEC when a company insider, such as a director, buys or sells shares of their company's stock. It provides transparency to the market regarding insider transactions.

Stakeholder Impact

• The purchase of shares by a director could positively influence shareholder sentiment.

Key Dates